Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Rowaida Refaat"'
Autor:
Yasmin El Zouka, Eman Sheta, Mona Abdelrazek Salama, Eman Selima, Rowaida Refaat, Sherihan Salaheldin Abdelhamid Ibrahim
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-19 (2024)
Abstract Atherosclerosis (AS) is a major cause of cardiovascular diseases that may lead to mortality. This study aimed to evaluate the therapeutic potential of tetrandrine in high cholesterol diet (HCD)-induced atherosclerosis, in rats, via modulatio
Externí odkaz:
https://doaj.org/article/4a391b7a9a8d43e5aa86ccb6154de4e9
Publikováno v:
Archives of Pharmaceutical Sciences Ain Shams University, Vol 4, Iss 1, Pp 104-112 (2020)
Diabetic nephropathy (DN) is the most frequent cause of the end-stage renal disease (ESRD) in about 33% of diabetic patients. The present study aimed to explore the renoprotective effects of simvastatin (SV) and rosuvastatin (RSU) on the kidney of st
Externí odkaz:
https://doaj.org/article/f37af0454a504ab1a9b82a905368ac3c
Autor:
Ibrahim, Sherihan Salaheldin Abdelhamid, Salama, Mona Abdelrazek, Selima, Eman, Shehata, Rowaida Refaat
Publikováno v:
In Life Sciences 1 November 2020 260
Publikováno v:
Archives of Pharmaceutical Sciences Ain Shams University, Vol 4, Iss 1, Pp 104-112 (2020)
Diabetic nephropathy (DN) is the most frequent cause of the end-stage renal disease (ESRD) in about 33% of diabetic patients. The present study aimed to explore the renoprotective effects of simvastatin (SV) and rosuvastatin (RSU) on the kidney of st
Autor:
Marwa B. Bakir, Mennatallah A. Ali, Maher A. Kamel, Eman A. Khalifa, Mona Salama, Rowaida Refaat
Publikováno v:
European Journal of Pharmacology. 847:72-82
Defect in one-carbon metabolism is one of the multiple underlying pathological pathways contributing to NAFLD pathogenesis. Hence, our study was designed to examine whether different one-carbon donors; betaine, choline, and folic acid would possess b
Autor:
Rowaida Refaat, Mennatallah A. Gowayed, Hanan S. El-Abhar, Ahmed S. Attia, Kathrin Rothe, Ulf Wagner, Christoph Baerwald, Manuela Rossol
Publikováno v:
Biochemical pharmacology. 170
Objective The evolution of the “cholinergic anti-inflammatory pathway” and the fact that the α 7 subunit of the nicotinic acetylcholine receptor (α7nAChR) is present in the spleen, joint and on the surface of lymphocytes, opened up the prospect
Publikováno v:
Drug Development Research. 77:300-309
Preclinical Research The majority of studies on vildagliptin and pioglitazone have focused on their combination in glycemic control. The aim of the present study was to investigate their effects in combination on (i) hyperglycemia-induced oxidative s
Publikováno v:
Pharmacological reports : PR. 70(2)
The present study aimed to investigate the possible post-irradiation protective effects of ectoine on CNS and testes of male mice. The study included thirty male Swiss albino mice (20–22 gm). Mice were divided into five groups (six each); controls
Publikováno v:
European Journal of Pharmacology. 714:448-455
Increasing evidence has established causative links between obesity, chronic inflammation and insulin resistance; the core pathophysiological feature in type 2 diabetes mellitus. This study was designed to examine whether the combination of L-cystein
Publikováno v:
European Journal of Pharmacology. 698:421-428
There is increasing body of evidence documenting the involvement of angiotensin II in inflammatory diseases. Moreover the up-regulation of angiotensin II AT(1) receptors in the synovium of rheumatoid arthritis patients has been previously described.